Clinical Trial Update: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of Genalumab for injection in patients with active systemic juvenile idiopathic arthritis and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Genalumab

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Active Systemic Juvenile Idiopathic Arthritis | NA | Status: RECRUITING